Abstract
Gene expression analysis can unveil the genes associated with the molecular action of a drug. However, it is not always clear how the differentially expressed genes restore the phenotype and whether, globally, the drug has an effect on the disease. We propose a method that exploits gene-expression data and network biology information to build a mediation analysis model for the evaluation of the effect of treatment on the disease at molecular level. First, differentially expressed genes (DEGs) associated to the drug and the disease are discovered. Then, based on a pathway analysis, shortest paths between drug DEGs and disease DEGs are obtained. This allows discovering the mediator genes that connect drug genes to disease genes. The expression values of the three sets of genes are used to conduct a mediation analysis that evaluates the effect of the drug on the disease. The effect could be direct, indirect by mediators, or both. The latent variables and mediation model are constructed by using the PLS-SEM. The procedure is applied to a real example concerning the effect of abacavir on HIV samples. The proposed pipeline can offer an additional tool for the understanding of the etiology of a disease and unveiling the mechanisms of action of a drug at gene level.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Clarke, P.A., et al.: Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential. Biochem. Pharmacol. 62(10), 1311–1336 (2001)
Barabási, A.L., Gulbahce, N., Loscalzo, J.: Network medicine: a network-based approach to human disease. Nat. Rev. Genet. 12(1), 56–68 (2011)
Baron, R.M., Kenny, D.A.: The moderator-mediator variable distinction in social psychological research – conceptual, strategic, and statistical considerations. J. Pers. Soc. Psychol. 51(6), 1173–1182 (1986)
Gunzler, D., Chen, T., Wu, P., Zhang, H.: Introduction to mediation analysis with structural equation modeling. Shanghai Arch. Psychiatry 25(6), 390 (2013). doi:10.3969/j.issn/1002-0829.2013.06.009
MacKinnon, D.: Introduction to Statistical Mediation Analysis. Lawrence Erlbaum Associates, New York (2008). doi:10.4324/9780203809556
Kanehisa, M., Goto, S.: KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28(1), 27–30 (2000)
Pepe, D., Grassi, M.: Investigating perturbed pathway modules from gene expression data via structural equation models. BMC Bioinform. 15(1), 1–15 (2014)
Hair Jr., J.F., et al.: A Primer on Partial Least Squares Structural Equation Modeling (PLS-SEM). Sage Publications, Los Angeles (2013)
Hair, J.F., Ringle, C.M., Sarstedt, M.: PLS-SEM: indeed a silver bullet. J. Market. Theory Pract. 19(2), 139–152 (2011)
Mohsen, S., et al.: Differential adipose tissue gene expression profiles in abacavir treated patients that may contribute to the understanding of cardiovascular risk: a microarray study. PLoS ONE 10(1), e0117164 (2015)
Tusher, V.G., Tibshirani, R., Chu, G.: Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. 98(9), 5116–5121 (2001)
Tarca, A.L., et al.: A novel signaling pathway impact analysis. Bioinformatics 25(1), 75–82 (2009)
Zhang, J.D., Wiemann, S.: KEGGgraph: a graph approach to KEGG PATHWAY in R and bioconductor. Bioinformatics 25(11), 1470–1471 (2009)
Pepe, D., Do, J.H.: Comparison of perturbed pathways in two different cell models for parkinson’s disease with structural equation model. J. Comput. Biol. 23(2), 90–101 (2016)
Pepe, D., Do, J.H.: Estimation of dysregulated pathway regions in MPP + treated human neuroblastoma SH-EP cells with structural equation model. BioChip J. 9(2), 131–138 (2015)
Monecke, A., Leisch, F.: semPLS: structural equation modeling using partial least squares. J. Stat. Softw. 48(3), 1–32 (2012)
Valdez, H., Lederman, M.M.: Cytokines and cytokine therapies in HIV infection. AIDS Clin. Rev. 187–228 (1996)
Kim, J.J., Simbiri, K.A., Sin, J.I., Dang, K., Oh, J., Dentchev, T., Lee, D., Nottingham, L.K., Chalian, A.A., Mccallus, D., Ciccarelli, R.: Cytokine molecular adjuvants modulate immune responses induced by DNA vaccine constructs for HIV-1 and SIV. J. Interferon Cytokine Res. 19(1), 77–84 (1999)
Manninen, A., Saksela, K.: HIV-1 NEF interacts with inositol trisphosphate receptor to activate calcium signaling in T cells. J. Exp. Med. 195(8), 1023–1032 (2002)
Manninen, A., Renkema, G.H., Saksela, K.: Synergistic activation of NFAT by HIV-1 NEF and the Ras/MAPK pathway. J. Biol. Chem. 275(22), 16513–16517 (2000)
Lindl, K.A., Marks, D.R., Kolson, D.L., Jordan-Sciutto, K.L.: HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities. J. Neuroimmune Pharmacol. 5(3), 294–309 (2010)
Vance, D.E.: Olfactory and psychomotor symptoms in HIV and aging: potential precursors to cognitive loss. Med. Sci. Monitor 13, SC1–SC3 (2007)
Zucco, G.M., Ingegneri, G.: Olfactory deficits in HIV-infected patients with and without AIDS dementia complex. Physiol. Behav. 80, 669–674 (2004)
Freeman, E.E., Weiss, H.A., Glynn, J.R., Cross, P.L., Whitworth, J.A., Hayes, R.J.: Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. Aids 20(1), 73–83 (2006)
Moorman, J., Zhang, Y., Liu, B., LeSage, G., Chen, Y., Stuart, C., Prayther, D., Yin, D.: HIV-1 gp120 primes lymphocytes for opioid-induced, β-arrestin 2-dependent apoptosis. Biochimica et Biophysica Acta (BBA)-Molecular Cell Res. 1793(8), 1366–1371 (2009)
Jones, K.L., De Kretser, D.M., Patella, S., Phillips, D.J.: Activin A and follistatin in systemic inflammation. Mol. Cell. Endocrinol. 225(1), 119–125 (2004)
Phillips, D.J., de Kretser, D.M., Hedger, M.P.: Activins and related proteins in inflammation: not just interested bystanders. Cytokine Growth Factor Rev. 20(2), 153–164 (2009)
Levi, G., et al.: Human immunodeficiency virus coat protein gp120 inhibits the beta-adrenergic regulation of astroglial and microglial functions. Proc. Natl. Acad. Sci. 90(4), 1541–1545 (1993)
Di Clemente, N., Jamin, S.P., Lugovskoy, A., Carmillo, P., Ehrenfels, C., Picard, J.Y., Whitty, A., Josso, N., Pepinsky, R.B., Cate, R.L.: Processing of anti-mullerian hormone regulates receptor activation by a mechanism distinct from TGF-β. Mol. Endocrinol. 24(11), 2193–2206 (2010)
Lotz, M., Clark-Lewis, I., Ganu, V.: HIV-1 transactivator protein Tat induces proliferation and TGF beta expression in human articular chondrocytes. J. Cell Biol. 124(3), 365–371 (1994)
Acknowledgement
This research was funded by the MIMOmics grant of the European Union’s Seventh Framework Programme (FP7-Health-F5-2012) under the grant agreement number 305280.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this paper
Cite this paper
Pepe, D., Burzykowski, T. (2017). PLS-SEM Mediation Analysis of Gene-Expression Data for the Evaluation of a Drug Effect. In: Bracciali, A., Caravagna, G., Gilbert, D., Tagliaferri, R. (eds) Computational Intelligence Methods for Bioinformatics and Biostatistics. CIBB 2016. Lecture Notes in Computer Science(), vol 10477. Springer, Cham. https://doi.org/10.1007/978-3-319-67834-4_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-67834-4_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-67833-7
Online ISBN: 978-3-319-67834-4
eBook Packages: Computer ScienceComputer Science (R0)